BMC Clinical Pharmacology

unofficial impact factor 1.36

Open Access Email this article to a friend

EVITA: a tool for the early EValuation of pharmaceutical Innovations with regard to Therapeutic Advantage

Isabel Püntmann, Norbert Schmacke, Arne Melander, Gunnar Lindberg and Bernd Mühlbauer*

BMC Clinical Pharmacology 2010, 10:5 doi:10.1186/1472-6904-10-5

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.